Inventor
SONG NANMENG
CN9 patents
⚠️ This page may combine multiple inventors who share the name “SONG NANMENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BEIJING HANMI PHARMACEUTICAL CO LTD
6 patentsUS11319378B2May 3, 2022
Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing the same
BEIJING HANMI PHARMACEUTICAL CO LTD3 citations70
US11498977B2Nov 15, 2022
Heterodimeric immunoglobulin constructs and preparation methods thereof
BEIJING HANMI PHARMACEUTICAL CO LTD2 citations68
US11753471B2Sep 12, 2023
Anti-PD-1/anti-HER2 natural antibody structural heterodimeric bispecific antibody and method of preparing same
BEIJING HANMI PHARMACEUTICAL CO LTD1 citations59
US11827697B2Nov 28, 2023
Anti-PD-1/anti-VEGF natural antibody structure like heterodimeric form bispecific antibody and preparation thereof
BEIJING HANMI PHARMACEUTICAL CO LTD1 citations54
US11739151B2Aug 29, 2023
Anti-PD-L1/anti-CD47 bispecific antibody
BEIJING HANMI PHARMACEUTICAL CO LTD0 citations49
US12325743B2Jun 10, 2025
Anti-TNFα/anti IL-17A natural antibody structure-like heterodimer form of bispecific antibody and preparation method therefor
BEIJING HANMI PHARMACEUTICAL CO LTD0 citations44
Beijing hanmi pharm co ltd
3 patentsUS11117967B2Sep 14, 2021
Antibody specifically binding to PD-1 and functional fragment thereof
Beijing hanmi pharm co ltd2 citations66
US11072651B2Jul 27, 2021
Antibody specifically binding to IL-17A, encoding nucleic acid, and method of using the antibody
Beijing hanmi pharm co ltd2 citations66
US11591409B2Feb 28, 2023
Anti-PD-L1/anti-PD-1 natural antibody structure-like heterodimeric bispecific antibody and preparation thereof
Beijing hanmi pharm co ltd0 citations46